← Human Trials & Peer-Reviewed Studies

Beyond Glycemia: The Role of Vitamin D and Iron Biomarkers in Diabetes Mellitus.

Plain-language guide to PMID 42047140 (2026): observational study of Vitamin D, K2, Magnesium and Zinc in 2025 participants.

Key Facts

PMID
42047140
Journal
La Clinica terapeutica
Year
2026
Study type
Observational Study
Authors
Amjad Z et al. (5 authors)
DOI
10.7417/CT.2026.2038

What This Study Did, in Plain Language

What Was Tested

This observational study looks at Vitamin D, K2, Magnesium and Zinc.

The aim is to evaluate the association between serum vitamin D, ferritin, and hemoglobin levels and glycemic status, as measured by fasting blood glucose (FBS) and glycated hemoglobin (HbA1c), among adult patients attending a tertiary care hospital in Al-Ahsa, Saudi Arabia.

Why It Was Studied

This report proposes research that examines correlations between vitamin D, hemoglobin, ferritin, and diabetes for the Saudi Arabian population.

Who Took Part

According to the abstract, 2025 participants were involved.

By PubMed's age tags, the people studied were adults and middle-aged adults, both men and women.

This Cross-sectional study was carried out in King Faisal Polyclinics in Al-Ahsa, Kingdom of Saudi Arabia between Aug 2024 and Jan 2025 on 249 participants (proportional sampling for both genders).

How the Study Was Run

The variables were measured for Fasting Blood Sugar (FBS) levels, HbA1c%, Hemoglobin (Hb), Ferritin level, and Vitamin D level.

All analyses were done in SPSS software version 26.

Correlation analysis between variables were done by using One-Way ANOVA and Pearson's Chi-Square Tests.

What Was Measured

Topics PubMed links to this paper include Vitamin D, Ferritins, Biomarkers, Cross-Sectional Studies, Glycated Hemoglobin, Saudi Arabia and Blood Glucose.

The authors tagged it with the keywords Diabetes Mellitus and Glycemic Control.

What This Means in Plain Language

This is an observational study of Vitamin D, K2, Magnesium and Zinc in 2025 participants.

With several hundred people or more, it is a fairly large study for this kind of research.

Results are reported in around 7 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2026 (La Clinica terapeutica), a journal based in Italy.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.